A more well-defined lower body with no sagging skin or extra fat in the thighs can greatly improve your appearance. However, the thighs are one area where fat accumulates fast and refuses to go way despite diets and exercise. If you are bothered about excess fat or sagging skin in this area of the body, thigh lift surgery at bodySCULPT® in Manhattan, New York City (NYC) can provide the solution. Our plastic surgeons perform inner and outer thigh lift procedures using advanced safe and effective minimally-invasive techniques.
At bodySCULPT®, we perform thigh lift using BodyTite™. This novel Radiofrequency Assisted Liposuction (RFAL) device from Invasix simultaneously firms and tightens skin quickly, with minimal risk and downtime. This superior body contouring device tightens the underlying muscles and reduces saggy skin with negligible scarring. If there is a substantial amount of fatty tissue in the thigh area, we might recommend liposuction of the surplus fat either prior to or in combination with the surgery. We utilize the minimally invasive, laser-enabled Smartlipo Triplex™ which blends safety with efficiency to perform body contouring.
At our surgical practice, a thigh lift can address various issues:
bodySCULPT® has a team of qualified, talented plastic surgeons who will provide you with a customized solution after a careful evaluation of your anatomy and aesthetic goals. The use of minimally invasive techniques minimizes side effects, surgical trauma and downtime. Other benefits of treatment at this reliable AAAASF-accredited practice include
To learn more about our outer or inner thigh lift procedure or to schedule a consultation, call 1-800-282-7285 or send a mail to firstname.lastname@example.org.
BodyTite™ is a sophisticated device using patented radiofrequency assisted liposuction (RFAL) technology for effective body contouring and significant skin contraction. BodyTite™ is a new innovative technique that bodySCULPT® is bringing to it's patients. The plastic surgeons at bodySCULPT® have been selected to head the IRB study in New York for FDA approval.